Condition: Schizophrenia · Schizophreniform Disorders · Schizo Affective Disorder · Sponsor: The Alfred
To study the effect of adjunctive bazedoxifene - a selective estrogen receptor modulator (SERM) in a double blind, placebo-controlled adjunctive study in the treatment of women with schizophrenia. All patients receive standardized antipsychotic medication.
This description comes directly from the study's public registry record.
Anthony de Castella · +61 390766564 · Anthony.decastella@monash.edu
MAPrc · +61 390766564 · maprc@monash.edu
Always discuss trial participation with your own doctor first.
| Multidisciplinary Alfred Psychiatry Research Centre | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04113993